This week Complete Rolling Submission of New Drug Application of Brigatinib with priority review? ...FDA informs the applicant of a Priority Review designation within 60 days of the receipt of the original BLA, NDA, or efficacy supplement... http://www.fda.gov/ForPatients/Approvals/Fast/ucm405405.htm link